AY

Anshu Yadav

Active Director Designated Partner DIN 10381335
DIN 10381335 First appointment Dec 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Anshu Yadav

Data last updated:

Anshu Yadav is a Designated Partner at Srk Pharma Llp (since 2023). The company operates in Business Services.

DIN 10381335
Primary Designation Designated Partner
Industry Business Services
First Appointment 05 Dec 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srk Pharma Llp ACA-0684
Designated Partner05 Dec 20232023Active

Board colleagues of Anshu Yadav

NameDINCompanyDesignation
Rekha Singh10416011Srk Pharma LlpDesignated Partner
Sanjay Ramsakal Yadav10379313Srk Pharma LlpDesignated Partner
Yasar Naushad Akram10379241Srk Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Srk Pharma Llp
Premium access

Shareholding and investment profile for Anshu Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshu Yadav

Anshu Yadav currently holds 1 directorship: Srk Pharma Llp (Designated Partner, since 05 Dec 2023).

Anshu Yadav was first appointed on 05 Dec 2023 as Designated Partner at Srk Pharma Llp.

The current boards of Anshu Yadav's companies include Rekha Singh (Srk Pharma Llp), Sanjay Ramsakal Yadav (Srk Pharma Llp), Yasar Naushad Akram (Srk Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available